Kisqali 200mg Tablet 42 ‘S

Description:

• Kisqali 200mg Tablet 42 ‘S is prescribed in treating symptoms of Breast cancer in women with HR positive and HER-2 negative type of local or metastatic breast cancer.
• Kisqali 200mg Tablet 42 ‘S contains Ribociclib as an active ingredient.
• Kisqali 200mg Tablet 42 ‘S is taken orally with or without meals usually once a day in the morning (following a cycle of around 21 days with a gap of 7 days) or as prescribed by the doctor.
• Kisqali 200mg Tablet 42 ‘S is to be used only when necessary